211 related articles for article (PubMed ID: 33670554)
1. MiRNAs in Canine and Human Osteosarcoma: A Highlight Review on Comparative Biomolecular Aspects.
Leonardi L; Scotlandi K; Pettinari I; Benassi MS; Porcellato I; Pazzaglia L
Cells; 2021 Feb; 10(2):. PubMed ID: 33670554
[TBL] [Abstract][Full Text] [Related]
2. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
[TBL] [Abstract][Full Text] [Related]
3. miR-1 and miR-133b expression in canine osteosarcoma.
Leonardo L; Laura P; Serena BM
Res Vet Sci; 2018 Apr; 117():133-137. PubMed ID: 29272721
[TBL] [Abstract][Full Text] [Related]
4. Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart.
Angstadt AY; Motsinger-Reif A; Thomas R; Kisseberth WC; Guillermo Couto C; Duval DL; Nielsen DM; Modiano JF; Breen M
Genes Chromosomes Cancer; 2011 Nov; 50(11):859-74. PubMed ID: 21837709
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling of canine osteosarcoma reveals genes associated with short and long survival times.
Selvarajah GT; Kirpensteijn J; van Wolferen ME; Rao NA; Fieten H; Mol JA
Mol Cancer; 2009 Sep; 8():72. PubMed ID: 19735553
[TBL] [Abstract][Full Text] [Related]
6. A genome-wide approach to comparative oncology: high-resolution oligonucleotide aCGH of canine and human osteosarcoma pinpoints shared microaberrations.
Angstadt AY; Thayanithy V; Subramanian S; Modiano JF; Breen M
Cancer Genet; 2012 Nov; 205(11):572-87. PubMed ID: 23137772
[TBL] [Abstract][Full Text] [Related]
7. Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progression.
Paoloni M; Davis S; Lana S; Withrow S; Sangiorgi L; Picci P; Hewitt S; Triche T; Meltzer P; Khanna C
BMC Genomics; 2009 Dec; 10():625. PubMed ID: 20028558
[TBL] [Abstract][Full Text] [Related]
8. Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.
Fenger JM; London CA; Kisseberth WC
ILAR J; 2014; 55(1):69-85. PubMed ID: 24936031
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma.
Sarver AL; Thayanithy V; Scott MC; Cleton-Jansen AM; Hogendoorn PC; Modiano JF; Subramanian S
Orphanet J Rare Dis; 2013 Jan; 8():7. PubMed ID: 23311495
[TBL] [Abstract][Full Text] [Related]
10. Distinct mechanisms of PTEN inactivation in dogs and humans highlight convergent molecular events that drive cell division in the pathogenesis of osteosarcoma.
Sarver AL; Mills LJ; Makielski KM; Temiz NA; Wang J; Spector LG; Subramanian S; Modiano JF
Cancer Genet; 2023 Aug; 276-277():1-11. PubMed ID: 37267683
[TBL] [Abstract][Full Text] [Related]
11. Understanding the Osteosarcoma Pathobiology: A Comparative Oncology Approach.
Varshney J; Scott MC; Largaespada DA; Subramanian S
Vet Sci; 2016 Jan; 3(1):. PubMed ID: 29056713
[TBL] [Abstract][Full Text] [Related]
12.
Sakthikumar S; Elvers I; Kim J; Arendt ML; Thomas R; Turner-Maier J; Swofford R; Johnson J; Schumacher SE; Alföldi J; Axelsson E; Couto CG; Kisseberth WC; Pettersson ME; Getz G; Meadows JRS; Modiano JF; Breen M; Kierczak M; Forsberg-Nilsson K; Marinescu VD; Lindblad-Toh K
Cancer Res; 2018 Jul; 78(13):3421-3431. PubMed ID: 29724721
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs in osteosarcoma: from biological players to clinical contributors, a review.
Zhou G; Shi X; Zhang J; Wu S; Zhao J
J Int Med Res; 2013 Feb; 41(1):1-12. PubMed ID: 23569124
[TBL] [Abstract][Full Text] [Related]
14. Reference gene validation for gene expression normalization in canine osteosarcoma: a geNorm algorithm approach.
Selvarajah GT; Bonestroo FAS; Timmermans Sprang EPM; Kirpensteijn J; Mol JA
BMC Vet Res; 2017 Nov; 13(1):354. PubMed ID: 29178874
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs as Biomarkers in Canine Osteosarcoma: A New Future?
Gourbault O; Llobat L
Vet Sci; 2020 Sep; 7(4):. PubMed ID: 33008041
[TBL] [Abstract][Full Text] [Related]
16. Intra- and interspecies gene expression models for predicting drug response in canine osteosarcoma.
Fowles JS; Brown KC; Hess AM; Duval DL; Gustafson DL
BMC Bioinformatics; 2016 Feb; 17():93. PubMed ID: 26892349
[TBL] [Abstract][Full Text] [Related]
17. miR-196a expression in human and canine osteosarcomas: a comparative study.
Pazzaglia L; Leonardi L; Conti A; Novello C; Quattrini I; Montanini L; Roperto F; Del Piero F; Di Guardo G; Piro F; Picci P; Benassi MS
Res Vet Sci; 2015 Apr; 99():112-9. PubMed ID: 25599934
[TBL] [Abstract][Full Text] [Related]
18. Heterotypic mouse models of canine osteosarcoma recapitulate tumor heterogeneity and biological behavior.
Scott MC; Tomiyasu H; Garbe JR; Cornax I; Amaya C; O'Sullivan MG; Subramanian S; Bryan BA; Modiano JF
Dis Model Mech; 2016 Dec; 9(12):1435-1444. PubMed ID: 27874835
[TBL] [Abstract][Full Text] [Related]
19. MiR-34a regulates the invasive capacity of canine osteosarcoma cell lines.
Lopez CM; Yu PY; Zhang X; Yilmaz AS; London CA; Fenger JM
PLoS One; 2018; 13(1):e0190086. PubMed ID: 29293555
[TBL] [Abstract][Full Text] [Related]
20. Role of miR-142 in the pathogenesis of osteosarcoma and its potential as therapeutic approach.
Shabani P; Izadpanah S; Aghebati-Maleki A; Baghbani E; Baghbanzadeh A; Fotouhi A; Bakhshinejad B; Aghebati-Maleki L; Baradaran B
J Cell Biochem; 2019 Apr; 120(4):4783-4793. PubMed ID: 30450580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
